{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:23:28Z","timestamp":1773303808358,"version":"3.50.1"},"reference-count":70,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T00:00:00Z","timestamp":1492992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of Health-ricerca corrente","award":["201502P003496"],"award-info":[{"award-number":["201502P003496"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0175784","type":"journal-article","created":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T17:30:01Z","timestamp":1493055001000},"page":"e0175784","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Use of short interfering RNA delivered by cationic liposomes to enable efficient down-regulation of PTPN22 gene in human T lymphocytes"],"prefix":"10.1371","volume":"12","author":[{"given":"Valentina","family":"Perri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marsha","family":"Pellegrino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Ceccacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Scipioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Petrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Gianchecchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Lo Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"De Santis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Fierabracci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,4,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"R241","DOI":"10.1530\/EJE-14-0047","article-title":"Mechanisms in endocrinology: autoimmune thyroid disease: old and new players","volume":"170","author":"G Effraimidis","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1210\/er.2013-1055","article-title":"Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity","volume":"35","author":"SM McLachlan","year":"2014","journal-title":"Endocr Rev"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"MA Atkinson","year":"2014","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e636","DOI":"10.1016\/j.lpm.2012.10.003","article-title":"Pancreatic islet autoimmunity","volume":"41","author":"C Boitard","year":"2012","journal-title":"Presse Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.autrev.2015.05.002","article-title":"Associated autoimmune diseases in children and adolescents with type 1 diabetes mellitus (T1D)","volume":"14","author":"K Kakleas","year":"2015","journal-title":"Autoimmun Rev"},{"key":"ref6","first-page":"266","article-title":"The urgent need to prevent type 1 autoimmune childhood diabetes","volume":"12","author":"Z Laron","year":"2015","journal-title":"Pediatr Endocrinol Rev"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.2147\/DDDT.S79322","article-title":"Insulin administration: present strategies and future directions for a noninvasive (possibly more physiological) delivery","volume":"9","author":"E Matteucci","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000363162","article-title":"Clinical aspects of Hashimoto\u2019s thyroiditis","volume":"26","author":"G Radetti","year":"2014","journal-title":"Endocr Dev"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.2174\/138161211798157577","article-title":"New prospects for treatment of autoimmune diseases","volume":"17","author":"A Fierabracci","year":"2011","journal-title":"Curr Pharm Des"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1089\/thy.2010.1639","article-title":"Genetics of the autoimmune polyglandular syndrome type 3 variant","volume":"20","author":"M Dittmar","year":"2010","journal-title":"Thyroid"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1111\/j.1365-2362.2010.02366.x","article-title":"Endocrine autoimmune disease: genetics become complex","volume":"40","author":"J Wiebolt","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.autrev.2013.05.003","article-title":"Recent insights into the role of the PD-1\/PD-L1 pathway in immunological tolerance and autoimmunity","volume":"12","author":"E Gianchecchi","year":"2013","journal-title":"Autoimmun Rev"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"19767","DOI":"10.1073\/pnas.0706233104","article-title":"Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases","volume":"104","author":"X Yu","year":"2007","journal-title":"Proc Natl Acad Sci. U S A"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/ng1673","article-title":"Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant","volume":"37","author":"T Vang","year":"2005","journal-title":"Nat Genet"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nature02119","article-title":"Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice","volume":"426","author":"N Sakaguchi","year":"2003","journal-title":"Nature"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.immuni.2013.06.013","article-title":"The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity","volume":"39","author":"Y Wang","year":"2013","journal-title":"Immunity"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.autrev.2012.12.003","article-title":"The putative role of the C1858T polymorphism of protein tyrosine phosphatase <italic>PTPN22<\/italic> gene in autoimmunity","volume":"12","author":"E Gianchecchi","year":"2013","journal-title":"Autoimmun Rev"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e110755","DOI":"10.1371\/journal.pone.0110755","article-title":"Altered B cell homeostasis and toll-like receptor 9-driven response in type 1 diabetes carriers of the C1858T <italic>PTPN22<\/italic> allelic variant: implications in the disease pathogenesis","volume":"9","author":"E Gianchecchi","year":"2014","journal-title":"PLoS ONE"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/nbt915","article-title":"Approaches for the sequence-specific knockdown of mRNA","volume":"21","author":"LJ Scherer","year":"2003","journal-title":"Nat Biotechnol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1021\/bc800540j","article-title":"Conjugation of antisense oligonucleotides to PEGylated carbon nanotubes enables efficient knockdown of PTPN22 in T lymphocytes","volume":"20","author":"LG Delogu","year":"2009","journal-title":"Bioconjug Chem"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.tranon.2015.03.010","article-title":"Targeting polo-like kinases: a promising therapeutic approach for cancer treatment","volume":"8","author":"X Liu","year":"2015","journal-title":"Transl Oncol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/path.2993","article-title":"Corey DR Gene silencing by siRNAs and antisense oligonucleotides in the laboratory and the clinic","volume":"226","author":"JK Watts","year":"2012","journal-title":"J Pathol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/mt.2016.4","article-title":"Inhibition of glycolate oxidase with dicer-substrate siRNA reduces calcium oxalate deposition in a mouse model of primary hyperoxaluria type 1","volume":"24","author":"C Dutta","year":"2016","journal-title":"Mol Ther"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"H Yin","year":"2014","journal-title":"Nat Rev Genet"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/jps.10399","article-title":"Innovations in oligonucleotide drug delivery","volume":"92","author":"MA Lysik","year":"2003","journal-title":"J Pharm Sci"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jim.2007.06.009","article-title":"Arginine-rich cell-penetrating peptides facilitate delivery of antisense oligomers into murine leukocytes and alter pre-mRNA splicing","volume":"325","author":"NB Marshall","year":"2007","journal-title":"J Immunol Methods"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1389200216666150401110211","article-title":"Nucleic acids delivery systems: a challenge for pharmaceutical technologists","volume":"16","author":"AC Silva","year":"2015","journal-title":"Curr Drug Metab"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s13346-012-0116-9","article-title":"Inorganic nanovectors for nucleic acid delivery","volume":"3","author":"S Pranatharthiharan","year":"2013","journal-title":"Drug Deliv Transl Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1166\/jnn.2008.501","article-title":"Cell-type specific and cytoplasmic targeting of PEGylated carbon nanotube-based nanoassemblies","volume":"8","author":"MH Cato","year":"2008","journal-title":"J Nanosci Nanotechnol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nnano.2008.68","article-title":"A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice","volume":"3","author":"ML Schipper","year":"2008","journal-title":"Nat Nanotechnol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"VP Torchilin","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2147\/IJN.S18647","article-title":"Type and composition of surfactants mediating gene transfection of polyethylenimine-coated liposomes","volume":"6","author":"P Opanasopit","year":"2011","journal-title":"Int J Nanomedicine"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae\u2014the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Y Barenholz","year":"2012","journal-title":"J Control Release"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s11060-007-9444-x","article-title":"Pegylated-liposomal doxorubicin and oral topotecan in eight children with relapsed high-grade malignant brain tumors","volume":"86","author":"S Wagner","year":"2008","journal-title":"J Neurooncol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.anl.2011.03.006","article-title":"Successful treatment of rhino-orbital mucormycosis by a new combination therapy with liposomal amphotericin B and micafungin","volume":"39","author":"T Ogawa","year":"2012","journal-title":"Auris Nasus Larynx"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ygyno.2011.04.019","article-title":"Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: analysis from the GCIG CALYPSO relapsing ovarian cancer trial","volume":"122","author":"F Joly","year":"2011","journal-title":"Gynecol Oncol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ygyno.2011.04.046","article-title":"Effects of bevacizumab and pegylated liposomal doxorubicin for the patients with recurrent or refractory ovarian cancers","volume":"122","author":"K Kudoh","year":"2011","journal-title":"Gynecol Oncol"},{"key":"ref38","first-page":"277","article-title":"Liposomal daunorubicin as treatment for Kaposi\u2019s sarcoma","volume":"2","author":"CE Petre","year":"2007","journal-title":"Int J Nanomedicine"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1002\/art.24434","article-title":"Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis","volume":"60","author":"E Andreakos","year":"2009","journal-title":"Arthritis Rheum"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"9333","DOI":"10.1021\/la061230f","article-title":"Role of the spacer stereochemistry on the aggregation properties of cationic gemini surfactants","volume":"22","author":"C Bello","year":"2006","journal-title":"Langmuir"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1021\/mp900173v","article-title":"Efficiency of liposomes in the delivery of a photosensitizer controlled by the stereochemistry of a gemini surfactant component","volume":"7","author":"C Bombelli","year":"2010","journal-title":"Mol Pharm"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"5378","DOI":"10.1021\/jm050477r","article-title":"Efficient transfection of DNA by liposomes formulated with cationic gemini amphiphiles","volume":"48","author":"C Bombelli","year":"2005","journal-title":"J Med Chem"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"10271","DOI":"10.1021\/la051324+","article-title":"Role of the spacer of cationic gemini amphiphiles in the condensation of DNA","volume":"21","author":"C Bombelli","year":"2005","journal-title":"Langmuir"},{"key":"ref44","first-page":"301","article-title":"Preparation of auxiliaries for asymmetric synthesis from tartaric acid. Addition of butyllithium to aldehydes in chiral media","volume":"60","author":"D Seebach","year":"1977","journal-title":"Helv Chim Acta"},{"key":"ref45","article-title":"Reduction of liposomes size and preparation of unilamellar vescicles by extrusion techniques in liposome technology","author":"MJ Hope","year":"1992"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cellsig.2004.07.008","article-title":"Phorbol 12-myristate 13-acetate upregulates cyclooxygenase-2 expression in human pulmonary epithelial cells via Ras, Raf-1, ERK, and NF-kappaB, but not p38 MAPK, pathways","volume":"17","author":"MS Chang","year":"2005","journal-title":"Cell Signal"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.3727\/096368915X687543","article-title":"Immunoregulatory Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles on T Lymphocytes","volume":"24","author":"A Del Fattore","year":"2015","journal-title":"Cell Transplant"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4612-5190-3","article-title":"Principles of Nucleic Acid Structure","author":"W Saenger","year":"1984"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1172\/JCI66963","article-title":"A disease-associated <italic>PTPN22<\/italic> variant promotes systemic autoimmunity in murine models","volume":"123","author":"X Dai","year":"2013","journal-title":"J Clin Invest"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4049\/jimmunol.133.1.123","article-title":"The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level","volume":"133","author":"A Weiss","year":"1984","journal-title":"J Immunol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.phrs.2014.07.004","article-title":". The rise, fall, and resurgence of immunotherapy in type 1 diabetes","volume":"98","author":"M Ben Nasr","year":"2015","journal-title":"Pharmacol Res"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S2213-8587(13)70172-4","article-title":"Improving diabetes care in resource-poor countries: challenges and opportunities","volume":"1","author":"MA Atkinson","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.2337\/db11-1452","article-title":"Through the fog: recent clinical trials to preserve \u03b2-cell function in type 1 diabetes","volume":"61","author":"CJ Greenbaum","year":"2012","journal-title":"Diabetes"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2217\/imt.14.104","article-title":"Impact of disease heterogeneity on treatment efficacy of immunotherapy in Type 1 diabetes: different shades of gray","volume":"7","author":"NJC Woittiez","year":"2015","journal-title":"Immunotherapy"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.2337\/db16-0061","article-title":"CRISPR-Cas9-mediated modification of the NOD mouse genome with Ptpn22R619W mutation increases autoimmune diabetes","volume":"65","author":"X Lin","year":"2016","journal-title":"Diabetes"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.4049\/jimmunol.1200150","article-title":"PTPN22 alters the development of regulatory T cells in the thymus","volume":"188","author":"CJ Maine","year":"2012","journal-title":"J Immunol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"e86677","DOI":"10.1371\/journal.pone.0086677","article-title":"Autoimmunity associated LYP-W620 does not impair thymic negative selection of autoreactive T cells","volume":"9","author":"DJ Wu","year":"2014","journal-title":"PLoS ONE"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"896","DOI":"10.2337\/db12-0929","article-title":"<italic>PTPN22<\/italic> silencing in the NOD model indicates the type 1 diabetes-associated allele is not a loss-of-function variant","volume":"62","author":"P Zheng","year":"2013","journal-title":"Diabetes"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3389\/fcimb.2015.00095","article-title":"Genetic variations of <italic>PTPN2<\/italic> and <italic>PTPN22<\/italic>: role in the pathogenesis of Type 1 diabetes and Crohn&apos;s disease","volume":"5","author":"RC Sharp","year":"2015","journal-title":"Front Cell Infect Microbiol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/ng.904","article-title":"The autoimmune disease-associated <italic>PTPN22<\/italic> variant promotes calpain-mediated Lyp\/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness","volume":"43","author":"J Zhang","year":"2011","journal-title":"Nat Genet"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.clim.2015.02.003","article-title":"Nanoparticle-based autoimmune disease therapy","volume":"160","author":"P Serra","year":"2015","journal-title":"Clin Immunol"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.clim.2015.03.016","article-title":"A brief glimpse over the horizon for type 1 diabetes nanotherapeutics","volume":"160","author":"Y Garciafigueroa","year":"2015","journal-title":"Clin Immunol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nnano.2009.151","article-title":"Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice","volume":"4","author":"LA Mitchell","year":"2009","journal-title":"Nat Nanotechnol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1007\/s12272-011-1109-9","article-title":"Designing micro- and nano-particles for treating rheumatoid arthritis","volume":"34","author":"S Mitragotri","year":"2011","journal-title":"Arch Pharm Res"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.imlet.2013.12.018","article-title":"Nanomedicine in autoimmunity","volume":"158","author":"X Clemente-Casares","year":"2014","journal-title":"Immunol Lett"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"e0127057","DOI":"10.1371\/journal.pone.0127057","article-title":"Use of autoantigen-loaded phosphatidylserine-liposomes to arrest autoimmunity in type 1 diabetes","volume":"10","author":"I Pujol-Autonell","year":"2015","journal-title":"PLoS ONE"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/ng1323","article-title":"A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes","volume":"36","author":"N Bottini","year":"2004","journal-title":"Nat Genet"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nchembio.916","article-title":"LYP inhibits T-cell activation when dissociated from CSK","volume":"8","author":"T Vang","year":"2012","journal-title":"Nat Chem Biol"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.clim.2013.05.001","article-title":"Anti-CD3 clinical trials in type 1 diabetes mellitus","volume":"149","author":"AG Daifotis","year":"2013","journal-title":"Clin Immunol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/nbt.1539","article-title":"Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs","volume":"27","author":"J Hu","year":"2009","journal-title":"Nat Biotechnol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0175784","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T07:40:28Z","timestamp":1692776428000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0175784"}},"subtitle":[],"editor":[{"given":"Petr","family":"Heneberg","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,4,24]]},"references-count":70,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0175784","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,24]]}}}